The European Parliament’s ongoing work on a cardiovascular health own initiative report has exposed a number of political fault lines. While the file touches on many important issues including prevention screening and access to care few topics have generated as clear and concentrated a conflict as nicotine pouches.
According to reporting by Euractiv the debate around tobacco and nicotine has become increasingly polarised.
A closer look at the amendment table confirms this picture. Nicotine pouches have become one of the most ideologically charged issues in the entire report despite appearing in only a narrow set of paragraphs. Not necessarily by number of amendmend
A narrow paragraph a wide divide
All substantive proposals concerning nicotine pouches and other non combustible nicotine products are concentrated in paragraphs ten and eleven of the draft resolution. Across the full range of amendments these sections account for roughly twenty amendments while the rest of the report including large sections on clinical prevention and cardiovascular risk management does not include nicotine products.
Two camps two fundamentally different logics
The amendments clearly fall into two opposing camps.
On one side amendments tabled by members from the Socialists and Democrats the Greens and allied voices argue that all nicotine products should be treated alike regardless of form. Their proposals consistently call for full inclusion of nicotine pouches in the Tobacco Products Directive identical rules to those applied to combustible tobacco and broad restrictions justified by precautionary language.
What stands out however is what these amendments do not contain. None of the proposals from this camp refer to scientific evidence relative risk assessment or product specific characteristics. Instead they largely restate a normative position that nicotine is nicotine and regulation should therefore be identical. Surprisingly, very much in line with the Patriots for Europe/Fidesz commissioner Varhelyis position that recently has been heavily criticized, simply for not being true nor in line with scientific consensus.
This is difficult to reconcile with the stated objective of improving public health outcomes. Treating fundamentally different products as if they posed identical risks runs counter to basic principles of evidence based regulation particularly in a health context.
A risk based evidence aware alternative
On the other side of the debate amendments from ECR members and several EPP representatives adopt a markedly different tone. These proposals emphasize proportionality and scientific evidence the distinction between combustible and non-combustible products and the importance of regulating according to actual risk profiles rather than category labels.
Among the most balanced contributions are those associated with Jessica Polfjärd (EPP) and likeminded colleagues. Their amendments neither deny the need for regulation nor downplay youth protection but insist that public health policy must follow evidence rather than ideology.
A similar logic is reflected in amendments tabled by Kristoffer Storm. His proposals consistently emphasize relative risk and proportionality and explicitly distinguish between combustible and non combustible nicotine products. Rather than arguing for blanket treatment Storm anchors his amendments in the idea that regulation should correspond to actual health risk and exposure driven primarily by combustion. This places his contributions firmly in the evidence based camp and reinforces the view that a growing group of members see harm reduction and scientific differentiation not as ideological preferences but as prerequisites for credible public health policy.
This latter approaches reflect a basic but often forgotten principle. Public health is best served when regulation is aligned with scientific consensus especially when different products demonstrably carry different levels of harm.
Why this matters beyond Parliament
It is worth recalling that this report is an own initiative resolution. It will not create law. But it will send a strong political signal.
That signal matters because the European Commission has recently adopted a position on nicotine pouches and other smoke free products that runs counter to a growing body of scientific evidence as noted by researchers and clinicians across disciplines. The Commission’s stance has already been criticized for disregarding relative risk and harm reduction principles a critique documented in detail in earlier analysis published on Pouchforum.
The Parliament now faces a choice. It can either reinforce that disconnect by endorsing blanket evidence light approaches or it can reassert the importance of science based proportionate policymaking.
More than a technical disagreement
There are many legitimate and important debates in this file. But nicotine pouches stand out because the disagreement is not about margins or drafting technique. It is about whether EU health policy should distinguish between products based on their actual risks or whether it should deliberately ignore those differences.
For a Parliament that routinely proclaims its commitment to evidence-based policymaking and the highest possible level of public health protection the answer should not be controversial.
Whether the final report reflects that principle will be closely watched not only by consumers and researchers but also by a Commission that has increasingly drifted away from scientific consensus on smoke free alternatives.